doi: 10.1038/s41380-024-02498-5
Am J Surg Pathol (2005) 29:114551
Individuals with a history of allergic reactions to Liraglutide or other related allergies Those with a history of thyroid cancer Individuals with endocrine disorders People with kidney, liver, intestinal, or stomach problems Those taking diabetes medications or blood-thinning medications Individuals under 18 years of age or over 75 years old Pregnant women, those planning to become pregnant, or individuals currently breastfeeding Is the GLP-1 program Safe
The One Growth Hormone Peptide That Is FDA Approved If FDA approval matters to you, there is one growth hormone peptide that has it: Tesamorelin
Current Pharmaceutical Design, 19(1), 126-132
This analysis estimates clinical eligibility and use of GLP-1 drugs among adults under age 65 in the private and employer-sponsored insurance (ESI) markets using the 2023 National Health Interview Survey (NHIS) and Merative MarketScan commercial claims data